UPDATE 2-Palomar shares up as FDA OKs OTC laser device
Reuters - Palomar’s home-use device is designed as an alternative to laser hair removal procedures normally performed by doctors and trained cosmetic professionals in clinics, spas and salons. Shares of the company traded as high as $58.10 earlier on Monday











